- Home
- SABS vs BBGI Comparison
SABS vs BBGI Comparison
Compare SABS & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- BBGI
- Stock Information
- Founded
- SABS 2014
- BBGI 1961
- Country
- SABS United States
- BBGI United States
- Employees
- SABS N/A
- BBGI N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- BBGI Broadcasting
- Sector
- SABS Health Care
- BBGI Consumer Discretionary
- Exchange
- SABS Nasdaq
- BBGI Nasdaq
- Market Cap
- SABS 15.8M
- BBGI 13.2M
- IPO Year
- SABS N/A
- BBGI 2000
- Fundamental
- Price
- SABS $1.85
- BBGI $6.00
- Analyst Decision
- SABS Strong Buy
- BBGI
- Analyst Count
- SABS 6
- BBGI 0
- Target Price
- SABS $11.17
- BBGI N/A
- AVG Volume (30 Days)
- SABS 58.6K
- BBGI 4.2K
- Earning Date
- SABS 05-27-2025
- BBGI 05-07-2025
- Dividend Yield
- SABS N/A
- BBGI N/A
- EPS Growth
- SABS N/A
- BBGI N/A
- EPS
- SABS N/A
- BBGI N/A
- Revenue
- SABS $377,835.00
- BBGI $234,823,730.00
- Revenue This Year
- SABS N/A
- BBGI $5.02
- Revenue Next Year
- SABS $50.00
- BBGI N/A
- P/E Ratio
- SABS N/A
- BBGI N/A
- Revenue Growth
- SABS N/A
- BBGI N/A
- 52 Week Low
- SABS $1.00
- BBGI $4.80
- 52 Week High
- SABS $5.01
- BBGI $15.00
- Technical
- Relative Strength Index (RSI)
- SABS 58.32
- BBGI 56.04
- Support Level
- SABS $1.76
- BBGI $5.30
- Resistance Level
- SABS $2.15
- BBGI $6.20
- Average True Range (ATR)
- SABS 0.19
- BBGI 0.38
- MACD
- SABS 0.02
- BBGI 0.05
- Stochastic Oscillator
- SABS 51.61
- BBGI 78.57
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.